
Masimo (MASI) Stock Forecast & Price Target
Masimo (MASI) Analyst Ratings
Bulls say
Masimo is a medical technology company that operates in the healthcare segment, with a focus on patient monitoring technologies and hospital automation solutions. The company has a strong pipeline of new products and is dedicated to generating evidence for clinical outcomes and cost of care reductions. Masimo also has a diverse customer base, including hospitals, emergency medical services, and physician offices. With a consistent track record of HSD top-line growth and guidance for a 7%-10% revenue CAGR, along with a projected 30% operating margin and $8 adjusted EPS by 2028, Masimo shows a sustainable outlook with a potential for consistent performance in the MedTech industry.
Bears say
Masimo is facing significant challenges, including ongoing legal battles, lack of diversification in their single business segment, and the need for aggressive market share expansion plans to meet their ambitious long-term targets. Recent refinancing activities and strategic initiatives may provide temporary relief from financial pressure, but the company's heavy reliance on pulse oximetry and other non-invasive patient monitoring technologies may leave them vulnerable to technological disruptions and competition in the future. The company's underlying adjusted EBIT margins have consistently fallen short of their long-term target, and tariffs could negatively impact future profitability.
This aggregate rating is based on analysts' research of Masimo and is not a guaranteed prediction by Public.com or investment advice.
Masimo (MASI) Analyst Forecast & Price Prediction
Start investing in Masimo (MASI)
Order type
Buy in
Order amount
Est. shares
0 shares